Detail
Article
Online article
FT
Medvik - BMC
  • Something wrong with this record ?

Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma

P. Busek, E. Balaziova, I. Matrasova, M. Hilser, R. Tomas, M. Syrucek, Z. Zemanova, E. Krepela, J. Belacek, A. Sedo,

. 2016 ; 37 (10) : 13961-13971. [pub] 20160804

Language English Country United States

Document type Comparative Study, Journal Article

Grant support
NT12237 MZ0 CEP Register

Glioblastomas are deadly neoplasms resistant to current treatment modalities. Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies. FAP is considered a potential therapeutic target and is associated with a worse patient outcome in some cancers. The FAP localization in the glioma microenvironment and its relation to patient survival are unknown. By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level. FAP expression was most elevated in the mesenchymal subtype of glioblastoma. It was neither associated with glioblastoma patient survival in our patient cohort nor in publicly available datasets. FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers. In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP. Endogenous FAP was frequently upregulated and part of the FAP(+) host cells coexpressed the CXCR4 chemokine receptor. In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth. The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.

References provided by Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17013600
003      
CZ-PrNML
005      
20191015075944.0
007      
ta
008      
170413s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1007/s13277-016-5274-9 $2 doi
035    __
$a (PubMed)27492457
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Bušek, Petr $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. busekpetr@seznam.cz. $7 xx0094315
245    10
$a Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma / $c P. Busek, E. Balaziova, I. Matrasova, M. Hilser, R. Tomas, M. Syrucek, Z. Zemanova, E. Krepela, J. Belacek, A. Sedo,
520    9_
$a Glioblastomas are deadly neoplasms resistant to current treatment modalities. Fibroblast activation protein (FAP) is a protease which is not expressed in most of the normal adult tissues but is characteristically present in the stroma of extracranial malignancies. FAP is considered a potential therapeutic target and is associated with a worse patient outcome in some cancers. The FAP localization in the glioma microenvironment and its relation to patient survival are unknown. By analyzing 56 gliomas and 15 non-tumorous brain samples, we demonstrate increased FAP expression in a subgroup of high-grade gliomas, in particular on the protein level. FAP expression was most elevated in the mesenchymal subtype of glioblastoma. It was neither associated with glioblastoma patient survival in our patient cohort nor in publicly available datasets. FAP was expressed in both transformed and stromal cells; the latter were frequently localized around dysplastic blood vessels and commonly expressed mesenchymal markers. In a mouse xenotransplantation model, FAP was expressed in glioma cells in a subgroup of tumors that typically did not express the astrocytic marker GFAP. Endogenous FAP was frequently upregulated and part of the FAP(+) host cells coexpressed the CXCR4 chemokine receptor. In summary, FAP is expressed by several constituents of the glioblastoma microenvironment, including stromal non-malignant mesenchymal cells recruited to and/or activated in response to glioma growth. The limited expression of FAP in healthy tissues together with its presence in both transformed and stromal cells suggests that FAP may be a candidate target for specific delivery of therapeutic agents in glioblastoma.
650    _2
$a dospělí $7 D000328
650    _2
$a senioři $7 D000368
650    _2
$a zvířata $7 D000818
650    _2
$a apoptóza $7 D017209
650    _2
$a nádorové biomarkery $x metabolismus $7 D014408
650    _2
$a western blotting $7 D015153
650    _2
$a studie případů a kontrol $7 D016022
650    _2
$a transformované buněčné linie $x metabolismus $x patologie $7 D002461
650    _2
$a proliferace buněk $7 D049109
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a fibroblasty $x metabolismus $x patologie $7 D005347
650    _2
$a následné studie $7 D005500
650    _2
$a želatinasy $x genetika $x metabolismus $7 D018093
650    _2
$a glioblastom $x genetika $x metabolismus $x patologie $7 D005909
650    _2
$a lidé $7 D006801
650    _2
$a imunoenzymatické techniky $7 D007124
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a membránové proteiny $x genetika $x metabolismus $7 D008565
650    _2
$a mezoderm $x metabolismus $x patologie $7 D008648
650    _2
$a myši $7 D051379
650    _2
$a myši inbrední NOD $7 D016688
650    _2
$a lidé středního věku $7 D008875
650    _2
$a staging nádorů $7 D009367
650    _2
$a prognóza $7 D011379
650    _2
$a messenger RNA $x genetika $7 D012333
650    _2
$a kvantitativní polymerázová řetězová reakce $7 D060888
650    _2
$a polymerázová řetězová reakce s reverzní transkripcí $7 D020133
650    _2
$a serinové endopeptidasy $x genetika $x metabolismus $7 D012697
650    _2
$a buňky stromatu $x metabolismus $x patologie $7 D017154
650    _2
$a míra přežití $7 D015996
650    _2
$a nádorové buňky kultivované $7 D014407
650    _2
$a xenogenní modely - testy protinádorové aktivity $7 D023041
655    _2
$a srovnávací studie $7 D003160
655    _2
$a časopisecké články $7 D016428
700    1_
$a Balážiová, Eva $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $7 xx0126036
700    1_
$a Matrasová, Ivana $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $7 xx0212899
700    1_
$a Hilšer, Marek, $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $d 1976- $7 xx0208340
700    1_
$a Tomáš, Robert $u Department of Neurosurgery, Na Homolce Hospital, Roentgenova 2, 150 30, Prague 5, Czech Republic. $7 xx0056248
700    1_
$a Syrůček, Martin $u Department of Pathology, Na Homolce Hospital, Roentgenova 2, 150 30, Prague 5, Czech Republic. $7 xx0145890
700    1_
$a Zemanová, Zuzana, $u Institute of Clinical Biochemistry and Laboratory Diagnostics of the First Faculty of Medicine, Charles University in Prague and General University Hospital in Prague, U Nemocnice 2, 128 01, Prague 2, Czech Republic. $d 1962- $7 nlk20050170627
700    1_
$a Křepela, Evžen $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. $7 xx0083612
700    1_
$a Belacek, Jaromir $u Institute of Biophysics and Bioinformatics, First Faculty of Medicine, Charles University in Prague, Salmovská 1, 120 00, Prague 2, Czech Republic.
700    1_
$a Šedo, Aleksi, $u Institute of Biochemistry and Experimental Oncology, First Faculty of Medicine, Charles University in Prague, U Nemocnice 5, 128 53, Prague 2, Czech Republic. aleksi@cesnet.cz. $d 1967- $7 jn20000605245
773    0_
$w MED00008757 $t Tumour biology the journal of the International Society for Oncodevelopmental Biology and Medicine $x 1423-0380 $g Roč. 37, č. 10 (2016), s. 13961-13971
856    41
$u https://pubmed.ncbi.nlm.nih.gov/27492457 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170413 $b ABA008
991    __
$a 20191015080409 $b ABA008
999    __
$a ok $b bmc $g 1200065 $s 974378
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 37 $c 10 $d 13961-13971 $e 20160804 $i 1423-0380 $m Tumor biology $n Tumor Biol $x MED00008757
GRA    __
$a NT12237 $p MZ0
LZP    __
$a Pubmed-20170413

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...